Cachexia

There are 237 papers on cachexia in aging research: 4 trials and 64 observational studies in people, 38 in animals, 1 in cells, 123 reviews. The newest story, Nov 5, 2026: “Exercise left lasting growth suppression in mouse tumor cells”.

Disease

237 papers study it433 more mention it79 findings

MeSH

21 new papers in 30 daysSee all 670 papers on cachexia

At a glance

Cachexia is linked with higher mortality in human cohorts with heart failure, cancer or dysphagia, and with cognitive and functional decline in older people with diabetes. Studies of people with dysphagia report no clear links with swallowing function or daily activities; exercise reduces cachexia in tumor-bearing mice and rats.

79 findings in 51 papers from 2007 to 2026, 6 of them since April 2026

“and indications of cachexia (lower albumin, creatinine, urea)-all statistically significant (P < 0.05).”
Novel blood signature for hepatocellular carcinoma screeningESMO gastrointestinal oncology2025doi:10.1016/j.esmogo.2025.100185
  • Human trial4
  • Humans64
  • Animals38
  • Cells1
  • In silico1

Interventions

13

Aerobic exercise

downin mice1downin rats1

2 studies
  1. Aerobic exercise decreases cachexia in mice (syngeneic colorectal cancer models).

    Animalssyngeneic colorectal cancer models

    Exercise left lasting growth suppression in mouse tumor cells

    iScience
  2. Aerobic exercise decreases cachexia in Walker-256 tumor-bearing rats (7.83 ± 1.75% vs 13.75 ± 1.71%, p < 0.05).

    Animalsin Walker-256 tumor-bearing rats6 weeksmalesn = 24

More on Aerobic exercise

Diet

downin humans1

1 study
  1. Diet decreases cachexia in humans (cancer treatment).

    Reviewcancer treatment

More on Diet

Physical activity

downin reviews1

1 study
  1. Physical activity decreases cachexia in cancer cachexia.

    Reviewin cancer cachexia

More on Physical activity

Voluntary wheel running

downin mice1

1 study
  1. Voluntary wheel running prevents cachexia in mice (C26 tumor-bearing mice).

    AnimalsC26 tumor-bearing mice4 weeksmales

More on Voluntary wheel running

Radiation

upin mice1

1 study
  1. Radiation induces cachexia in mice.

    Animals6.8 Gy

More on Radiation

SR12343

downin animals1

1 study
  1. SR12343 decreases cachexia during chemotherapy.

    Animalsduring chemotherapy

More on SR12343

Exercise

downin mice1

1 study
  1. Exercise decreases cachexia in tumor-bearing cachectic mice.

    Animalsin tumor-bearing cachectic mice

More on Exercise

GDF11

upin reviews1

1 study
  1. GDF11 induces cachexia.

    Reviewhigher doses

More on GDF11

TA-1887

downin mice1

1 study
  1. TA-1887 prevents cachexia in high-fat-fed db/db mice.

    Animalsin high-fat-fed db/db mice

More on TA-1887

Resistance training

downin rats1

1 study
  1. Resistance training prevents cachexia in Walker-256 tumor-bearing rats; exercise performed before tumor implantation.

    Animalsin Walker-256 tumor-bearing rats; exercise performed before tumor implantation6 weeksmalesn = 10

More on Resistance training

All 13

Effects

13

Swallowing function

no changein humans3

3 studies
  1. Cachexia was not clearly linked with swallowing function in humans (inpatients with dysphagia undergoing convalescent rehabilitation) (β=0.23, 95% CI -0.53 to 1.00, p=0.55).

    Humansinpatients with dysphagia undergoing convalescent rehabilitation56.1% womensn = 198

  2. Cachexia was not clearly linked with swallowing function in humans (non-sarcopenic dysphagia) (p = 0.585).

    Humansnon-sarcopenic dysphagian = 175

  3. Cachexia was not clearly linked with swallowing function in patients with sarcopenic dysphagia (7 versus 8, P = 0.849).

    Humansin patients with sarcopenic dysphagian = 271

Activities of daily living

no changein humans3

3 studies
  1. Cachexia was not clearly linked with activities of daily living in humans (inpatients with dysphagia undergoing convalescent rehabilitation) (β=0.03, 95% CI -0.10 to 0.15, p=0.66).

    Humansinpatients with dysphagia undergoing convalescent rehabilitation56.1% womensn = 198

  2. Cachexia was not clearly linked with activities of daily living in humans (non-sarcopenic dysphagia) (p = 0.469).

    Humansnon-sarcopenic dysphagian = 175

  3. Cachexia was not clearly linked with activities of daily living in patients with sarcopenic dysphagia (55 versus 52.5, P = 0.892).

    Humansin patients with sarcopenic dysphagian = 271

Physical function

downin humans3

3 studies
  1. Cachexia is linked with lower physical function in humans (post-stroke patients) (β=-0.092, P = 0.009).

    Humanspost-stroke patients85 daysn = 856

  2. Cachexia is linked with worse physical function in humans (heart failure).

    Humansheart failure

  3. Cachexia is linked with worse physical function in humans (patients undergoing hemodialysis).

    Humanspatients undergoing hemodialysis63 % malesn = 367

All-cause readmission

no changein humans1

1 study
  1. Cachexia was not clearly linked with all-cause readmission in humans (acute decompensated heart failure).

    Humansacute decompensated heart failuren = 78

Quality of life

downin humans1

1 study
  1. Cachexia impairs quality of life in older adults with cancer.

    Reviewin older adults with cancer

Discharge to home

no changein humans1

1 study
  1. Cachexia was not clearly linked with discharge to home in humans (inpatients with dysphagia undergoing convalescent rehabilitation) (β=0.25, 95% CI -0.75 to 1.35, p=0.63).

    Humansinpatients with dysphagia undergoing convalescent rehabilitation56.1% womensn = 198

Fibroblast activation protein-α

no changein humans1

1 study
  1. Cachexia was not clearly linked with fibroblast activation protein-α in humans.

    Humansn = 103

More on Fibroblast activation protein-α

Protein synthesis

downin mice1

1 study
  1. Cachexia decreases protein synthesis in mice after eccentric contractions, compared with healthy controls.

    Animalsafter eccentric contractions, compared with healthy controlsskeletal musclemales

P70S6K

no changein mice1

1 study
  1. Cachexia showed no clear effect on P70S6K in mice (ECC-induced P70S6K activation).

    AnimalsECC-induced P70S6K activationskeletal musclemales

More on P70S6K

Autophagy

upin reviews1

1 study
  1. Cachexia activates autophagy (cachectic muscle, contrasted with age-related defects in autophagy signaling).

    Reviewcachectic muscle, contrasted with age-related defects in autophagy signalingskeletal muscle

More on Autophagy

All 13

Upstream

1

MSTN

mediatesin reviews1

1 study
  1. MSTN mediates cachexia.

    Review

More on MSTN

Associations

32

Mortality

upin humans12HR 1.49–3.04

12 studies
  1. Cachexia is linked with a higher risk of mortality in humans (heart failure receiving home-visit rehabilitation) (HR 3.002, 95% CI 1.124–8.022).

    Humansheart failure receiving home-visit rehabilitationone yearn = 94

  2. Cachexia is linked with a higher risk of mortality in humans (acute decompensated heart failure) (HR 3.04).

    Humansacute decompensated heart failuren = 78

  3. Cachexia is linked with a higher risk of mortality in patients with dysphagia (OR: 7.98, 95 % CI: 3.08-24.7, P < 0.01).

    Humansin patients with dysphagian = 431

  4. Cachexia predicts mortality in humans (heart failure).

    Humansheart failure

  5. Cachexia is linked with a higher risk of mortality in patients with chronic diseases (49% vs 26%).

    Humansin patients with chronic diseases

  6. Cachexia is linked with a higher risk of mortality in humans (non-sarcopenic dysphagia) (17% vs. 1%, p = 0.002).

    Humansnon-sarcopenic dysphagian = 175

  7. Cachexia is associated with mortality in humans (patients undergoing hemodialysis) (HR 1.56, 95% CI 0.90-2.70).

    Humanspatients undergoing hemodialysis63 % malesn = 367

  8. Cachexia is linked with a higher risk of mortality in humans (patients undergoing hemodialysis) (HR 1.81, 95% CI 1.02-3.23).

    Humanspatients undergoing hemodialysis63 % malesn = 367

  9. Cachexia is linked with a higher risk of mortality in humans following transcatheter aortic valve replacement (aHR 2.51 (95% CI 1.11-5.65)).

    Humansfollowing transcatheter aortic valve replacement2-yearn = 234

  10. Cachexia is linked with a higher risk of mortality in humans (older adults with heart failure) (HR 1.494, 95% CI 1.173-1.903, P = 0.001).

    Humansolder adults with heart failure2 yearsn = 1,306

All 13

Type 1 diabetes

upin humans2OR 12.39–15.25

2 studies
  1. Type 1 diabetes is associated with cachexia in humans (elderly diabetic patients with chronic diseases) (OR 15.25, P=0.002).

    Humanselderly diabetic patients with chronic diseasesn = 242

  2. Type 1 diabetes is associated with cachexia in humans (elderly female diabetic patients) (OR 12.39, 95% CI 2.33-65.87).

    Humanselderly female diabetic patientsfemalesn = 171

More on Type 1 diabetes

Peak work rate

downin humans1

1 study
  1. Cachexia is associated with peak work rate in humans (Outpatients on maintenance hemodialysis; compared with patients without cachexia).

    HumansOutpatients on maintenance hemodialysis; compared with patients without cachexiafemale: 28.4%sn = 109

Falls

upin humans1OR 3.719

1 study
  1. Cachexia is linked with a higher risk of falls in humans (heart failure receiving home-visit rehabilitation) (OR 3.719, 95% CI 1.188–11.643).

    Humansheart failure receiving home-visit rehabilitationone yearn = 94

Older age

upin humans1

1 study
  1. Older age is associated with cachexia in humans (cancer undergoing oncological treatment) (p < 0.001).

    Humanscancer undergoing oncological treatmentn = 4,595

Hepatocellular carcinoma

upin humans1

1 study
  1. Hepatocellular carcinoma is associated with cachexia in chronic liver disease patients (P < 0.05).

    Humansin chronic liver disease patientsn = 223,862

More on Hepatocellular carcinoma

Amyotrophic lateral sclerosis

upin humans1

1 study
  1. Cachexia is linked with a higher risk of amyotrophic lateral sclerosis in humans.

    Humans

More on Amyotrophic lateral sclerosis

Post-discharge mortality

upin humans1HR 1.28–1.47

1 study
  1. Cachexia predicts post-discharge mortality in any of chronic diseases (HR 1.28 to 1.47).

    Humansin any of chronic diseases

SGLT2 inhibitors

downin humans1HR 0.453

1 study
  1. SGLT2 inhibitors are linked with a lower risk of cachexia in heart failure patients with prior anthracycline treatment (HR 0.453, 95% CI 0.286-0.718).

    Humansin heart failure patients with prior anthracycline treatment

More on SGLT2 inhibitors

Low SPPB scores

upin humans1OR 3.783

1 study
  1. Cachexia is associated with low SPPB scores in humans (heart failure undergoing outpatient cardiac rehabilitation) (OR 3.783, 95% CI 1.213-11.796).

    Humansheart failure undergoing outpatient cardiac rehabilitationn = 115

All 32

Trial sponsors

Funding

18 grants since 2017

National Institute on Aging$1MUS Department of Veterans AffairsSão Paulo Research Foundation

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 5Jan 2026: 8Feb 2026: 8Mar 2026: 13Apr 2026: 7May 2026: 7Jun 2026: 8Jul 2026: 12Aug 2026: 9Sep 2026: 7Oct 2026: 16Nov 2026: 10110 papers in 12 months
iScience

Exercise left lasting growth suppression in mouse tumor cells

In mouse experiments, colorectal cancer cells from exercised animals retained slower growth after repeated transplantation into untrained mice.In mouse experiments, colorectal cancer cells from exercised animals retained slower growth after repeated transplantation into untrained mice.

Mouse studyAerobic exercise

See all 670 papers on cachexia